PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! ...

Lawsuit Overview - Pacira BioSciences and certain executives are charged with failing to disclose material information during the Class Period, violating federal securities laws [3] - The lawsuit is pending in the United States District Court for the District of New Jersey [1] Key Events - On August 9, 2024, Pacira released results of its lawsuit against eVenus for patent infringement related to Exparel, which accounts for approximately 80% of the company's revenue [4] - The U S District Court for the District of New Jersey found that Pacira's U S Patent No 11,033,495 is not valid, meaning eVenus was not infringing on anything [4] - Following this news, Pacira's share price fell over 47%, from $22 36 per share on August 8, 2024 to a low of $11 70 per share on August 9, 2024 [5] Legal Actions - Investors who purchased Pacira securities between August 2, 2023 and August 8, 2024 have until March 14, 2025 to file lead plaintiff applications in the securities class action lawsuit [1] - The case is titled Alvarez v Pacira BioSciences, Inc, et al, No 25-cv-00322 [5]

Pacira BioSciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – PCRX ...

SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Pacira BioSciences, Inc. (NASDAQ: PCRX) securities between August 2, 2023 and August 8, 2024. Pacira is an American pharmaceutical company committed to developing and providing non-opioid pan management and regenerative health solutions. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (8 ...

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira BioSciences, Inc. Lawsuit - PCRX ...

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX ...

Shareholders of Pacira BioSciences, Inc. Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX ...

PCRX LAWSUIT ALERT: Levi & Korsinsky Notifies Pacira BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ...

The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Pacira BioSciences, Inc. ...

Group 1 - The article discusses a class action lawsuit against Pacira BioSciences, Inc. (PCRX) and notifies shareholders about an upcoming deadline related to the lawsuit [1] - The lawsuit is focused on allegations that the company may have misled investors regarding its business practices and financial performance [1] - Shareholders are encouraged to take action before the deadline to protect their rights and potentially recover losses [1]